Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Education
  • General
  • Health Care
  • Top Stories

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here’s How Much You’d Have Now

By Wayne Duggan
August 17, 7:04 PM
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

JNJ

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Hedge Funds
  • Media
  • Price Target
  • Trading Ideas

Why This Analyst Sees A 51% Return On This Cathie Wood-Favored Biotech Stock

By AJ Fabino
August 17, 6:33 PM
Biotech stocks have the potential for huge gains if a product or drug is deemed effective and safe, but investing in the shares of those companies can be volatile.

ARKK

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Penny Stocks
  • Small Cap

Recap Of Wednesday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan
August 17, 6:33 PM
The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat…

BLUE

Read More
1 minute read
  • Dividends
  • General
  • Hedge Funds
  • News
  • Trading Ideas

Invest Like Carolina Panthers Owner David Tepper With These 5 Big Dividend Stocks His Hedge Fund Owns

By Dylan Wechsler
August 17, 5:46 PM
David Tepper, the owner of the Carolina Panthers and founder of Appaloosa Management, has become a self-made billionaire through the hedge fund he manages and the gains from his stock portfolio.

AMLP

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • News
  • Penny Stocks
  • Small Cap

Independent Study Shows Cue Health’s Molecular COVID-19 Test is as Accurate as Lab-Based PCR Test

By Benzinga Newsdesk
August 17, 4:23 PM
SAN DIEGO, Calif., Aug. 17, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (NASDAQ: HLTH) announced today the preprint publication of an independent clinical study - the largest of itsSAN DIEGO, Calif., Aug. 17, 2022 /PRNewswire/ -- Cue Health Inc.

HLTH

Read More
3 minute read
  • General
  • Penny Stocks
  • Politics
  • Small Cap

Could A 17-Year-Old Revolutionize Electric Vehicles And Lower Reliance On China’s Rare Earth Metals?

By Melanie Schaffer
August 17, 3:55 PM
The West’s dependency on China for rare earth metals used in electric vehicle batteries has remained a top issue, both geopolitically and financially, for some time.

ALB

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • Contracts
  • General
  • Health Care
  • Movers
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

This Analyst Cuts I-Mab’s Price Target By 43%

By Vandana Singh
August 17, 3:24 PM
I-Mab (NASDAQ: IMAB) reported significant changes to the company's collaboration on developing CD47 targeting agents. 

ABBV

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Bluebird’s Gene Therapy Scores US Approval For Genetic Blood Disorder, Probably The Most Expensive

By Vandana Singh
August 17, 3:16 PM
The FDA has approved Bluebird bio Inc’s (NASDAQ:BLUE) Zynteglo (betibeglogene autotemcel), also known as beti-cel, a one-time gene therapy custom-designed for…

BLUE

Read More
3 minute read
  • General
  • Long Ideas
  • Short Ideas
  • Social Media
  • Technicals
  • Top Stories
  • Trading Ideas

What To Watch As Snapchap Parent Snap’s Stock Swings In This Trend

By Melanie Schaffer
August 17, 3:12 PM
Snaphat parent Snap, Inc (NYSE: SNAP) was trading over 5% lower at one point on Wednesday, and when the S&P 500 reacted bullishly to the monthly minutes released by the Federal Reserve, Snap failed to significantly follow suit.

SNAP

Read More
1 minute read
  • Education
  • General
  • News

Udemy Expands Global Footprint Via This Exclusive Partnership

By Shivani Kumaresan
August 17, 2:59 PM
Udemy Inc (NASDAQ:UDMY) said it is expanding into China through a partnership with digital transformation training provider Sanjieke. The partnership will enable…

UDMY

Posts pagination

Previous 1 … 2,221 2,222 2,223 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service